BioVitrum

BioVitrum is a manufacturer and distributor of medical diagnostic equipment and consumables.

History

2025: Placement of Series 001R-01 bonds for RUR 100 mln

BioVitrum placed exchange-traded bonds of the 001R-01 series for 100 million rubles at face value.

The issuer sold 100 thousand bonds with a par value of 1000 rubles each by open subscription. The term of circulation of securities is 3 years. Coupon period - 30 days. This was announced on April 2, 2025 by FinamBonds with reference to the organization's statement.

The coupon rate for the entire term of circulation of securities is set at 28.00% per annum. Initially, the benchmark for the 1st coupon rate was at the level of 28.00% per annum.

The bonds are subject to early repayment at the issuer's discretion on the end date of the 18th coupon period.

The organizer and placement agent is Renaissance Broker.

Bonds of the issue were placed under the program of exchange-traded bonds of the 001R series of 10 billion rubles inclusive or the equivalent of this amount in foreign currency^[1].

2020: Plans for the construction of a production and warehouse complex in the Leningrad region for 500 million rubles

On September 29, 2020, it became known that the Biovitrum company, which produces medical products, will build a production and warehouse complex in the Gorelovo industrial zone (Leningrad Region). Thanks to the transfer of capacities to the Leningrad region, the investor expects to increase his turnover to more than 1 billion rubles, which is twice as high as current indicators. Biovitrum plans to open this complex in January 2023.

Biovitrum will invest half a billion rubles in the creation of the production of medical reagents

Vladimir Tsimberg, General Director of Biovitrum LLC, told Kommersant about plans to build a production and warehouse complex in the Leningrad region. According to him, the company is in the process of buying a land plot of 2.5 hectares in the Gorelovo industrial zone, where the capacity will be located. On the territory of the complex, lines will be installed for the production of laboratory equipment from metal, consumables and reagents for the diagnosis of oncological diseases, microbiological media. In addition, it will house a laboratory of research and development work, warehouses and administrative premises. Investments in the project will amount to 500 million rubles of own and borrowed funds. According to preliminary estimates, deductions to the regional budget will be at least 70 million rubles a year.^[2]

One of the reasons for the move is the need to expand production facilities, explains Mr. Zimberg. As of September 2020, the company leases 5 thousand square meters. m on the territory of the former Priboy plant in St. Petersburg. The project in the Leningrad region will increase the area to 15 thousand square meters. m. The expansion of the laboratory complex and engineering group will make it possible to invest more in the creation of its own diagnostic products in the field of oncology and bacteriological research.

Biovitrum's plans for the construction of a production and warehouse complex are justified, since an import substitution program is being implemented on the medical device market, explains Nikolai Bespalov, Development Director of RNC Pharma. In addition, in the context of the devaluation of the ruble, prices for imported products are growing, which increases the attractiveness of domestic goods, he notes^[3] of ^[4].

2018: Plans to open an office in Europe

On June 1, 2018, it became known that Biovitrum plans to open its representative office in Europe. With the opening of the European office, the company expects to increase the share of paraffin supplied abroad in the total volume of products produced from 5% to 20% in two years.

We are talking, in particular, about the supply of a special paraffin medium for histological filling Histomix, which is used in laboratory diagnostics. Biovitrum already supplies this product to clinics in Kazakhstan and Belarus, and in 2017-2018 began to carry out its export supplies to Uzbekistan, Latvia, Serbia, China. The first deliveries are planned for Germany and Finland.

Vladimir Zimberg: BioVitrum will open an office in Europe to avoid administrative barriers. Photo: vademec.ru

As Vladimir Zimberg, General Director of Biovitrum, explained, an office in Europe will help the company avoid administrative barriers characteristic of the Russian market and excessive "regulation." In his opinion, the costs will be removed, the convenience of the company's work with clients and foreign suppliers will increase, there will be no unnecessary document management.

In Russia, we are under the influence of many regulatory services, which sometimes conflict with each other. This is a web in which we beat like a fly in the world, - stated Zimberg.

In addition, the European representation will provide advantages in logistics and CE certification (for compliance with the requirements of the European Union) and at the same time save the company from risks when the political situation changes, the head of Biovitrum is convinced.

The exact place for the establishment of a representative office in the company has not yet been named. However, it is known that the leadership of Biovitrum considers Germany as one of such places.

According to Zimberg, in the future, the European office may also engage in research and development (R&D), which is difficult to conduct in Russia for a number of reasons. Among them, the head of Biovitrum named logistics, the import of complex reagents and components, the increase in the cost of several times such supplies, which, in turn, entails the impossibility or difficulties for personnel in implementing their developments. In addition, there is a request for localization of production in other countries, such a possibility is not excluded, he concluded.^[5]

2017: St. Petersburg Warehouse Expansion

The relocation of BioVitrum's warehouse is the optimization of internal logistics processes, and the expansion of storage facilities, the greater cumulative capacity of which will allow you to respond faster to requests and sell orders.

2016: Launch of additional medical education courses for laboratory histologists

Programmy courses are based on training in modern methods and standards of work in a histological laboratory. Two fundamentals of the programs: narrow specialization and practical focus.

2015: Turnover exceeded RUB 2 bln

The turnover of BioVitrum LLC in 2015 amounted to 2 billion rubles.

2014

Release of PAC Histoviewer

V 2014, Biovitrum introduced Histoviewer, a unique hardware and software complex (PAC) that translates the process of pathological research, diagnostics and training to the advanced level of modern smart imaging technology and histological drug analysis.

At the time of designing the HistoViewer PAC, the issue of developing a convenient Russified program was acute, which would provide the necessary morphometric functionality for both a pathologist and a teacher of specialized universities. Each scanner manufacturer (Leica, 3DHistech, Hamamatsu, Aperio) has created its own proprietary software for viewing digitized images in English, which is not capable of working with competitive file formats. Thus, several file formats were created within the same goal and similar or similar characteristics, which made it difficult for users to work with them. Not one of the applications that existed at that time was adapted for touch screens.

Viktor Bovin, developer of PAC: "That is why the decision was made to develop PAC HistoViewer, which would provide convenient viewing on a large touch monitor of images of drugs that are scanned on scanners from various manufacturers. Additional important advantages were the Russian language and convenient intuitive morphometry. "

Launch the Histoscan.com Portal

In 2014, Biovitrum presented Histoscan.com, the first Russian portal for Digital Pathology. The Russian Society of Pathologists highly appreciated the capabilities and quality of the portal and recommends its use for the development of domestic telemedicine.

New division in the structure of the company - Life Science

In 2014, a new structural unit - Life Science combined two divisions: molecular and cellular biology and microscopy. The internal reorganization was carried out in order to improve the quality level of preparation of projects in the scientific segment.

Modernization of the full-cycle metal production shop

In 2014, BioVitrum upgraded its production facilities. Modern high-tech production specializes in the processing and manufacture of metal parts of any complexity. Complete production is organized, starting with drawing and creating 3D models, ending with complex design work.

====New range of dyes for histology Premium

In 2014, BioVitrum developed a new line of Premium histological dyes of its own production - kits and solutions for special painting methods. All products are certified and undergo strict quality control in the laboratory.

By this time, the company produces more than 1000 items of goods. The line is constantly expanding.

Opening an office in Vladivostok and a representative office in Yekaterinburg and Ufa

V 2014, the territorial presence of BioVitrum expanded immediately into two strategically significant regions of Russia - the Far Eastern (Vladivostok) and Ural (Yekaterinburg) federal districts. The company also strengthened its position in the Volga Federal District (Ufa ).

2012

Opening of in-house production of Sredoff microbiological media

In 2012, the company opened its own production of microbiological culture media for the isolation and identification of Sredoff microorganisms produced from English components.

2011: Opening of a representative office in Kazan

V 2011, a new representative office of the company was opened in the capital of the Republic of Tatarstan, in Kazan.

2010

Microbiology - A New Focus

Novoye business area of Microbiology began to develop rapidly and achieved significant market penetration. The main strategy is the emphasis on training specialists and the introduction of modern methods and technologies into the work of microbiological laboratories.

Opening of BioVitrum-Siberia branch

At the end of March 2010, the BioVitrum-Siberia branch was opened in Novosibirsk at Galushchak Street, 2A, office 26.  Earlier, the activities of BioVitrum in the Siberian Federal District were carried out by a regional representative and head office located in St. Petersburg. Thanks to the opening of a new office, the company plans to optimize logistics and distribution costs in the region, which will favorably affect prices for end customers. As part of the program to increase the availability of BioVitrum products on the basis of the BioVitrum-Siberia office, an assortment of product running positions is constantly being maintained.

2008

100% increase in turnover

V 2008, BioVitrum increased turnover by 100%.

Best Japanese Sakura Distributor

Po the end of 2008, Sakura (Japan) praised BioVitrum's achievements in product distribution. The award was presented to BioVitrum CEO Vladimir Tsimberg.

Opening a branch in Kazakhstan

Rasshireniye the geography of BioVitrum's presence - the opening of offices in Kazakhstan will allow us to cover new markets, be closer to customers, quickly respond to needs and implement projects of any complexity.

2007: Intensive growth of the company's turnover

In 2007, the company's intensive development led to the modernization of internal processes and the formation of a new customer service department. This allows BioVitrum to become more query-oriented of any nature and scale. The increase in the turnover of consumables leads to the expansion of the company's storage facilities.

2006

Opening a branch in Moscow

V 2006, the geographical development of the company led to the opening of a branch in Moscow. The most important and strategically important region of Russia, uniting a large number of clinical, diagnostic and scientific institutions concentrated in the central federal district. Presence in the capital has become a priority of the company.

Start-up of production of histological dyes

In 2006, a site for the production of solutions and dyes for histology was launched in St. Petersburg. Expansion and modernization of the company's chemical production. Advantages of the products of the Russian manufacturer: the use of high-quality raw materials comparable to imported products, careful professional quality control of each batch, verified step-by-step paint protocols, fast logistics and low cost of products.

2005: Service Service Organized

In 2005, the company's customer service service service was formed, which included specialists of a high professional level, confirmed by national and international certificates.

2001

Foundation of own chemical production

V 2001, BioVitrum opened its own production facilities in St. Petersburg. Chemical production was founded, the first medical product is the homogenized histological paraffin HISTOMIX, which is produced using the company's patented technology, ready for use. Consumables for histology under the BioVitrum brand appear on the Russian market.

Foundation of BioVitrum distributor

V 2001, BioVitrum was founded - a company distributor of medical and biological equipment and consumables in Russia from the world's leading manufacturers. The company's goal was not only the desire to modernize and reform biomedical laboratories equipped with high-tech equipment, but also the desire to develop the pathological service as a whole and approach it to world standards.

Notes